What are Catecholamine drugs?

Catecholamine drugs are pharmacologic agents that share a common mechanism (typically targeting D(1A) dopamine receptor). 3 are currently marketed, with 2 more in clinical development.

What are the marketed Catecholamine drugs?

Marketed Catecholamine drugs include Dopamine Hydrochloride, Norepinephrine Bitartrate In 5% Dextrose, Northera.

Catecholamine

3 marketed 1 in Phase 3 1 in Phase 2

This page covers all Catecholamine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting D(1A) dopamine receptor, alpha-adrenergic receptors, beta-adrenergic receptors, Muscarinic acetylcholine receptor M1.

Targets

D(1A) dopamine receptor · alpha-adrenergic receptors, beta-adrenergic receptors · Muscarinic acetylcholine receptor M1 · adrenergic receptors

Marketed (3)

Dopamine Hydrochloride · Cardiovascular
Dopamine Hydrochloride works by stimulating dopamine receptors in the body to increase heart rate, blood pressure, and cardiac output.
Norepinephrine Bitartrate In 5% Dextrose · Pfizer · Cardiovascular
Norepinephrine constricts blood vessels and stimulates the heart.
Northera · Lundbeck Na Ltd · Metabolic
Northera works by increasing the levels of certain neurotransmitters in the brain, such as norepinephrine, to help regulate blood pressure and movement.

Phase 3 pipeline (1)

dopamine versus norepinephrine · Sepsis Occurrence in Acutely Ill Patients · Cardiovascular
Dopamine and norepinephrine are catecholamine medications that work by stimulating the heart and increasing blood pressure.

Phase 2 pipeline (1)

Tanadopa · Neuroscience
Tanadopa works by increasing the levels of norepinephrine in the brain, which can help to improve alertness and attention.